Letter | Published:

Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis

Nature Genetics volume 40, pages 11031106 (2008) | Download Citation

  • A Corrigendum to this article was published on 01 April 2009

This article has been updated


Sarcoidosis is a complex chronic inflammatory disorder with predominant manifestation in the lung. In the first genome-wide association study (>440,000 SNPs) of this disease, comprising 499 German individuals with sarcoidosis and 490 controls, we detected a series of genetic associations. The strongest association signal maps to the ANXA11 (annexin A11) gene on chromosome 10q22.3. Validation in an independent sample (1,649 cases, 1,832 controls) confirmed the association (SNP rs2789679: P = 3.0 × 10−13, rs7091565: P = 1.0 × 10−5, allele-based test). Extensive fine mapping located the association signal to a region between exon 5 and exon 14 of ANXA11. A common nonsynonymous SNP (rs1049550, C > T, R230C) was found to be strongly associated with sarcoidosis. The GWAS lead SNP and additional risk variants in the region (rs1953600, rs2573346, rs2784773) were in strong linkage disequilibrium with rs1049550. Annexin A11 has complex and essential functions in several biological pathways, including apoptosis and proliferation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Change history

  • 24 March 2009

    NOTE: In the version of this article initially published, the SNP rs1049550 listed in the abstract was indicated incorrectly as a T>C change. It is a C>T change. On the third page of the article, the haplotype containing rs1049550 was incorrectly listed as TATACC. It should be AGCATT. These errors have been corrected in the HTML and PDF versions of the article.


  1. 1.

    , & Sarcoidosis. N. Engl. J. Med. 357, 2153–2165 (2007).

  2. 2.

    , & Sarcoidosis. Lancet 361, 1111–1118 (2003).

  3. 3.

    et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am. J. Respir. Crit. Care Med. 164, 840–846 (2001).

  4. 4.

    et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. 6, 509–518 (2005).

  5. 5.

    et al. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum. Genet. 120, 420–430 (2006).

  6. 6.

    et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am. J. Hum. Genet. 77, 491–499 (2005).

  7. 7.

    et al. BTNL2 gene variant and sarcoidosis. Thorax 61, 273–274 (2006).

  8. 8.

    et al. Patterns of linkage disequilibrium in the MHC region on human chromosome 6p. Hum. Genet. 114, 377–385 (2004).

  9. 9.

    et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet. 37, 357–364 (2005).

  10. 10.

    & Calcium- and cell cycle-dependent association of annexin 11 with the nuclear envelope. J. Biol. Chem. 278, 20210–20216 (2003).

  11. 11.

    , , & Annexinopathies. Subcell. Biochem. 45, 1–28 (2007).

  12. 12.

    et al. Determination of autoantibodies to annexin XI in systemic autoimmune diseases. Lupus 9, 515–520 (2000).

  13. 13.

    & Annexins: from structure to function. Physiol. Rev. 82, 331–371 (2002).

  14. 14.

    & The annexins. Genome Biol. 5, 219 (2004).

  15. 15.

    , & Calcyclin-binding site located on the NH2-terminal domain of rabbit CAP-50 (annexin-XI): functional expression of CAP-50 in Escherichia coli. Arch. Biochem. Biophys. 303, 302–306 (1993).

  16. 16.

    , , , & ALG-2 interacts with the amino-terminal domain of annexin XI in a Ca2+-dependent manner. Biochem. Biophys. Res. Commun. 291, 1166–1172 (2002).

  17. 17.

    , , , & S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 282, 31317–31331 (2007).

  18. 18.

    , & Interfering with apoptosis: Ca2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521–525 (1996).

  19. 19.

    , , & Dissociation of apoptosis and activation of IL-1beta-converting enzyme/Ced-3 proteases by ALG-2 and the truncated Alzheimer's gene ALG- 3. J. Immunol. 158, 5129–5135 (1997).

  20. 20.

    , , & Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ. 6, 124–129 (1999).

  21. 21.

    et al. Molecular components of a cell death pathway activated by endoplasmic reticulum stress. J. Biol. Chem. 279, 177–187 (2004).

  22. 22.

    et al. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells. J. Cell. Biochem. 103, 1183–1197 (2008).

  23. 23.

    , , & IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4, 329–336 (1996).

  24. 24.

    et al. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3, 1124–1128 (1997).

  25. 25.

    et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157, 910–918 (1996).

  26. 26.

    et al. IL-15, an immunomodulator of T cell responses in intracellular infection. J. Immunol. 158, 800–806 (1997).

Download references


The authors wish to thank all individuals with sarcoidosis, families and physicians for their cooperation. The efforts of the German Sarcoidosis Patients Organization (Deutsche Sarkoidose-Vereinigung) and the contribution of pulmonary specialist physicians are gratefully acknowledged. The authors wish to thank T. Wienker, M. Steffens, M. Albrecht, T. Wesse and C. von der Lanken for expert technical help, R. Kleindorp and G. Richter for logistic help, and R. Vogler for database and computer support. This study was funded by the German National Genome Research Network (NGFN-2).

Author information


  1. Institute of Clinical Molecular Biology, Christian Albrechts University, Kiel D-24105, Germany.

    • Sylvia Hofmann
    • , Andre Franke
    • , Annegret Fischer
    • , Gunnar Jacobs
    • , Philip Rosenstiel
    •  & Stefan Schreiber
  2. Institute of Medical Informatics and Statistics, Christian Albrechts University, Kiel D-24105, Germany.

    • Michael Nothnagel
    •  & Michael Krawczak
  3. Research Center Borstel, Borstel D-23845, Germany.

    • Karoline I Gaede
  4. Institute of Human Genetics, University of Lübeck, Lübeck D-23538, Germany.

    • Manfred Schürmann
  5. Department of Pneumology, University of Freiburg, Freiburg D-79106, Germany.

    • Joachim Müller-Quernheim
  6. Department of Internal Medicine, Christian Albrechts University, Kiel D-24105, Germany.

    • Stefan Schreiber


  1. Search for Sylvia Hofmann in:

  2. Search for Andre Franke in:

  3. Search for Annegret Fischer in:

  4. Search for Gunnar Jacobs in:

  5. Search for Michael Nothnagel in:

  6. Search for Karoline I Gaede in:

  7. Search for Manfred Schürmann in:

  8. Search for Joachim Müller-Quernheim in:

  9. Search for Michael Krawczak in:

  10. Search for Philip Rosenstiel in:

  11. Search for Stefan Schreiber in:


S.H. performed the SNP selection, genotyping and data analysis, drafted the manuscript and prepared the tables and parts of the figures; A.Franke and A.Fischer helped with data analysis and contributed to the design and the writing of the manuscript; G.J. and P.R. performed the protein, immunohistochemistry and cDNA experiments and contributed to the manuscript; M.K. supervised the statistical analysis and edited the paper; M.N. performed the haplotype analysis and helped with data analysis; M.S. and J.M.-Q. coordinated the recruitment, collected the phenotype data and contributed to the writing of the manuscript; K.I.G. provided the bronchoalveolar lavage and transbronchial biopsy samples; S.H. and S.S. jointly designed and supervised the experiment and wrote the manuscript.

Corresponding author

Correspondence to Stefan Schreiber.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Methods, Supplementary Tables 1–3, Supplementary Figures 1–4

About this article

Publication history






Further reading